Dramatic shift in gut microbes and their metabolites seen after weight loss surgery
Category Archives: AZBio News
Sergio Gazic Joins BioAccel as CEO
Sergio Gazic, former Bioscience Portfolio Manager at the Arizona Commerce Authority, began his new role as Chief Executive Officer of BioAccel on Monday, May 22, 2017. Continue reading
EpiFinder, Inc. Announces Analytics Software to Improve Epilepsy Diagnosis and Seizure Events
EpiFinder, Inc., announced its proprietary clinical decision analytics software to improve epilepsy syndrome diagnosis and seizure event management at the point-of-care. The early-stage Arizona company provides intelligent analytics and support to doctors, neurologists and healthcare professionals (Nurse Practitioners, Physician Assistants, and more) to enhance the lives of patients with epilepsy.Continue reading
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and healthcare-associated infections.Continue reading
The Collaborative Gene and its impact on Life Science Ecosystem Development: An Arizona Business Case
On May 12, 2017, Governor Doug Ducey signed Arizona’s $9.8 billion 2018-2019 Budget which provides bonding authority for $1 billion for investments in University Research Infrastructure. This investment continues a collaboration between the State of Arizona, Industry Leaders, Philanthropists, and Arizona’s Universities that is driving Arizona towards its goal of becoming a top-tier bioscience state.Continue reading
In The Loop for the week of May 15, 2017
| News and Events for Arizona’s Bioindustry |
|
This White Hat Presenting Company just closed its funding at 157% of its target
The White Hat Life Science Investor Conference is hosted by AZBio and its regional partners in California, Colorado, Montana, New Mexico, and Utah in even numbered years. In odd numbered years, the region hosts the Rocky Mountain Life Science Investor and Partnering Conference in Colorado. Application are currently open for the October conference in Vail. Continue reading
Oxford Finance and Silicon Valley Bank Close $20 Million Credit Facility with Castle Biosciences
“Castle Biosciences is focused on delivering high value tests to improve cancer treatment. This expanded capital facility will be used to accelerate growth of our cutaneous melanoma test, DecisionDx®-Melanoma, and support our near-term pipeline,” said Derek Maetzold, president and chief executive officer of Castle Biosciences.Continue reading
VisionGate Seeks to Diagnose and Prevent Lung Cancer
Congresswoman Kyrsten Sinema visits Phoenix Arizona based VisionGate to meet with employees and learn about this innovative life science company.Continue reading